Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Gynther

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Brain Research Bulletin|April 6, 2026
Characterisation of a patient-derived iPSC-based model for studying the blood-brain barrier in Alzheimer's diseaseSylvia Wagner, Karin Danz, Jooseppi Hyvärinen, et al.
Neuropharmacology|November 27, 2012
UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801Jesper T Andreasen, Anders Bach, Mikko Gynther, et al.
Neurochemical Research|July 15, 2016
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain ExposureMikko Gynther, Lauri Peura, Monika Vernerová, et al.
Neurobiology of Disease|April 26, 2022
Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease modelElena Puris, Seppo Auriola, Sabrina Petralla, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Laparoscopic Roux-en-Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 substratesElena Puris, Markku Pasanen, Veli-Pekka Ranta, et al.
International Journal of Pharmaceutics|February 4, 2021
Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and ratsAaro J Jalkanen, Jouni Ihalainen, Marko Lehtonen, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse ModelElena Puris, Seppo Auriola, Paula Korhonen, et al.
Journal of Medicinal Chemistry|January 26, 2008
Large neutral amino acid transporter enables brain drug delivery via prodrugsMikko Gynther, Krista Laine, Jarmo Ropponen, et al.
International Journal of Pharmaceutics|August 24, 2010
Brain uptake of ketoprofen-lysine prodrug in ratsMikko Gynther, Aaro Jalkanen, Marko Lehtonen, et al.
Analytical and Bioanalytical Chemistry|October 14, 2016
A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urineElena Puris, Markku Pasanen, Mikko Gynther, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Brain Research Bulletin|April 6, 2026
Characterisation of a patient-derived iPSC-based model for studying the blood-brain barrier in Alzheimer's diseaseSylvia Wagner, Karin Danz, Jooseppi Hyvärinen, et al.
Neuropharmacology|November 27, 2012
UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801Jesper T Andreasen, Anders Bach, Mikko Gynther, et al.
Neurochemical Research|July 15, 2016
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain ExposureMikko Gynther, Lauri Peura, Monika Vernerová, et al.
Neurobiology of Disease|April 26, 2022
Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease modelElena Puris, Seppo Auriola, Sabrina Petralla, et al.
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Laparoscopic Roux-en-Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 substratesElena Puris, Markku Pasanen, Veli-Pekka Ranta, et al.
International Journal of Pharmaceutics|February 4, 2021
Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and ratsAaro J Jalkanen, Jouni Ihalainen, Marko Lehtonen, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse ModelElena Puris, Seppo Auriola, Paula Korhonen, et al.
Journal of Medicinal Chemistry|January 26, 2008
Large neutral amino acid transporter enables brain drug delivery via prodrugsMikko Gynther, Krista Laine, Jarmo Ropponen, et al.
International Journal of Pharmaceutics|August 24, 2010
Brain uptake of ketoprofen-lysine prodrug in ratsMikko Gynther, Aaro Jalkanen, Marko Lehtonen, et al.
Analytical and Bioanalytical Chemistry|October 14, 2016
A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urineElena Puris, Markku Pasanen, Mikko Gynther, et al.
Pageof 6